Corpus Intelligence IC Memo — GRANT BLACKFORD MENTAL HEALTH INC. 2026-04-26 17:27 UTC
IC Memo — GRANT BLACKFORD MENTAL HEALTH INC.
Investment Committee Memorandum | IN | 16 beds | Grade D | EBITDA uplift $831K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

GRANT BLACKFORD MENTAL HEALTH INC.

CCN 154021 | nan, IN | 16 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

GRANT BLACKFORD MENTAL HEALTH INC. is a 16-bed under-performing / distressed in nan, IN with $11.2M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 7.4% Medicare, 6.8% Medicaid, and 85.7% commercial.

Thesis: Turnaround. Our ML models identify $831K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -139.4% (+740bps).

Net Revenue HCRIS$11.2M
Current EBITDA COMPUTED$-16.5M
Operating Margin COMPUTED-100.0%
Occupancy HCRIS35.2%
Revenue / Bed COMPUTED$702K
Net-to-Gross HCRIS94.4%
Distress Probability ML58.9%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
57
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of -100.0% places it below the state median. Among 57 size-comparable peers (8-32 beds), the median margin is -5.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-32), prioritizing same-state peers. 57 hospitals in the comp set.

HospitalStateBedsRevenueMargin
GRANT BLACKFORD MENTAL HEALTH (Target)IN16$11.2M-100.0%
MARGARET MARY COMMUNITY HOSPITIN25$124.5M-3.6%
FRANCISCAN HEALTH HAMMONDIN10$117.7M-4.3%
CAMERON MEMORIAL COMMUNITY HOSIN25$95.1M7.4%
THE OTIS R. BOWEN CENTERIN20$92.4M-11.2%
WHITLEY MEMORIAL HOSPITALIN30$87.8M1.1%
ADAMS MEMORIAL HOSPITALIN25$76.5M0.1%
DECATUR CO. MEMORIAL HOSPITALIN25$75.7M-19.8%
COMMUNITY HOSPITAL OF NOBLE CTIN31$71.4M1.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $831K (740bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$236K+210bp18mo
Cost to Collect4.5%2.5%$224K+200bp12mo
Denial Rate Reduction12.0%6.5%$224K+200bp12mo
A/R Days Reduction5200.0%3800.0%$137K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+9bp6mo

5. EBITDA Bridge

Net Collection Rate
$236K
Cost to Collect
$224K
Denial Rate Reduction
$224K
A/R Days Reduction
$137K
Clean Claim Rate
$10K
Total EBITDA Uplift$831K
Current EBITDA$-16.5M
+ RCM Uplift+$831K
Pro Forma EBITDA$-15.6M
Current Margin-100.0%
Pro Forma Margin-139.4%
WC Released (1x)$431K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-25.3M$-100.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-25.3M$-118.6M0.00x-100.0%
Bull Case9.0x11.0x$-22.8M$-124.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-22.8M$-142.1M0.00x-100.0%
Bear Case11.0x10.0x$-27.9M$-96.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-27.9M$-115.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
HighElevated distress probabilityModel estimates 58.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 57 hospitals with 8-32 beds
  • Same-state prioritization (n=59)
  • Comp margins: P25=-19.1% / P50=-5.8% / P75=3.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.